84.60
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $84.60, with a volume of 2.98M.
It is up +0.85% in the last 24 hours and down -4.44% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$83.89
Open:
$84.56
24h Volume:
2.98M
Relative Volume:
0.74
Market Cap:
$41.13B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
153.23
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
+3.15%
1M Performance:
-4.44%
6M Performance:
+8.66%
1Y Performance:
+32.77%
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VTR
Ventas Inc
|
84.60 | 41.13B | 6.13B | 272.21M | 1.38B | 0.5521 |
|
WELL
Welltower Inc
|
214.23 | 151.23B | 11.75B | 1.46B | 2.19B | -0.6014 |
|
DOC
Healthpeak Properties Inc
|
20.69 | 14.26B | 2.87B | 250.10M | 1.13B | 0.3188 |
|
OHI
Omega Healthcare Investors Inc
|
45.77 | 13.63B | 1.24B | 655.98M | 857.80M | 2.063 |
|
AHR
American Healthcare Reit Inc
|
46.81 | 9.68B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas Inc. Stock (US92276F1003): Insider ownership and institutional stakes in focus - AD HOC NEWS
Why Ventas (VTR) is a Great Dividend Stock Right Now - Yahoo Finance
Ventas, Inc. $VTR Stock Holdings Cut by GSI Capital Advisors LLC - MarketBeat
Ventas expects $3.86 FFO per share in 2026 as it raises investment plan to $3B - MSN
What's in the offing for Ventas stock this earnings season? - MSN
Bank of America Securities Sticks to Their Buy Rating for Ventas (VTR) - The Globe and Mail
O Shaughnessy Asset Management LLC Lowers Position in Ventas, Inc. $VTR - MarketBeat
Deutsche Bank AG Purchases 27,688 Shares of Ventas, Inc. $VTR - MarketBeat
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas stock (US92276F1003): healthcare REIT focuses on senior housing and medical offices - AD HOC NEWS
Ventas Inc Stock (US9227931050): Analyst Targets And Valuation Back In Focus After Recent Rally - AD HOC NEWS
Debra A. Cafaro, 55 - Crain's Chicago Business
Is Ventas Inc (VTR) Overvalued After 3.6% Rally? GF Value Says O - GuruFocus
Ventas stock (US92276F1003): Healthcare REIT focus after recent operating updates - AD HOC NEWS
Ventas Announces Second Quarter 2013 Earnings Release Date and Conference Call - AOL.com
Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In JuneCareTrust REIT (NYSE:CTRE), Ventas - Benzinga
How Investors Are Reacting To Ventas (VTR) Reaffirming Its Dividend And Senior Housing Outlook - simplywall.st
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ventas Inc. stock (US92276F1003): Healthcare REIT focuses on senior housing recovery and portfolio o - AD HOC NEWS
A Look At Ventas (VTR) Valuation After Updated Outlook And Dividend Reaffirmation - Yahoo Finance
Ventas Inc stock (US9227931050): Healthcare REIT focuses on senior housing recovery and capital recy - AD HOC NEWS
Ventas, Inc. $VTR Stock Holdings Decreased by TD Asset Management Inc - MarketBeat
Capital World Investors Purchases Shares of 7,677,904 Ventas, Inc. $VTR - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires New Stake in Ventas, Inc. $VTR - MarketBeat
Capital International Inc. CA Invests $8.43 Million in Ventas, Inc. $VTR - MarketBeat
(VTR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Ventas Inc. Stock Draws Aggressive Price Target Hikes - timothysykes.com
Vestcor Inc Lowers Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas Stock Climbs As Analysts Hike Price Targets And Guidance Holds - timothysykes.com
Insider Buying: Michael Embler Acquires Shares of Ventas Inc (VT - GuruFocus
Natixis Advisors LLC Sells 14,017 Shares of Ventas, Inc. $VTR - MarketBeat
Bank of New York Mellon Corp Buys 70,459 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Shares Bought by CIBC Asset Management Inc - MarketBeat
Ventas director Michael Embler acquires $197,025 in company stock - Investing.com UK
Ventas jumps as investors digest upbeat senior-housing update and 2026 outlook - Quiver Quantitative
Ventas director Michael Embler acquires $197,025 in company stock By Investing.com - Investing.com India
Ventas (VTR) director adds 2,500 shares in open-market purchase - Stock Titan
Daiwa Securities Group Inc. Has $364.12 Million Stake in Ventas, Inc. $VTR - MarketBeat
Cibc World Market Inc. Has $25.69 Million Holdings in Ventas, Inc. $VTR - MarketBeat
Top Ventas (VTR) Competitors 2026 - MarketBeat
Goldman Sachs Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $110 - Moomoo
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
REITs' fundamentals bode well for earnings outlook amid geopolitical uncertainty (DLR:NYSE) - Seeking Alpha
Ventas Stock Plummets 11% With 6-Day Losing Streak - Trefis
Ventas Stock 6-Day Losing Spree: Stock Falls -11% - Trefis
AVIP Intech U.S. Low Volatility Portfolio's Ventas Inc(VTR) Holding History - GuruFocus
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement - New Castle News
Morgan Stanley Maintains Ventas Inc(VTR.US) With Hold Rating, Maintains Target Price $90 - 富途牛牛
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):